Clinical trial
Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol Patch
NCT00185237 · Bayer, Industry · Completed
Key facts
| NCT number | NCT00185237 |
|---|---|
| Title | Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol Patch |
| Official title | A Multicenter, Double-blind, Randomized, Placebo Controlled Study on the Effect of Ultra-low Dose Transdermal Estradiol (Menostar®) on the Incidence and Severity of Hot Flushes, Other Menopausal Symptoms and on Well-being in Postmenopausal Asian Women Over 12 Weeks. |
| Lead sponsor | Bayer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hot Flashes |
| Intervention type | Drug |
| Interventions | Menostar (estradiol transdermal delivery system), Placebo |
| Enrollment | 165 |
| Start date | Jul 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 23, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: